In renal cell carcinoma, SF3B3 modulates EZH2 alternative splicing to promote carcinogenesis, and SF3B3 could be a potential prognostic factor and therapeutic target in renal cell carcinoma.87 This evidence concerns the gene SF3B3 and hereditary clear cell renal cell carcinoma.